SW1990, ATCC CRL-2172
SU.86.86, ATCC CRL-1837
BXPC-3, ATCC CRL-1687
Panc 10.05, ATCC CRL-2547
MIA-PaCa-2, ATCC CRL-1420
PANC-1, ATCC CRL-1469
Biological understanding of top genetic alterations in pancreatic cancer
Novel anti-cancer drug targeting
Reactivation of mutant p53
Studies related to p53 molecular mechanisms
Testing small molecules or biologics for cancer drug development
| Biological understanding of top genetic alterations in leukemia Novel anti-cancer drug targeting Reactivation of mutant p53 Studies related to p53 molecular mechanisms Testing small molecules or biologics for cancer drug development
Biosafety Level
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Comments
The Pancreatic Cancer p53 Hotspot Mutation Cell Panel is composed of six select adhesion cell lines derived from individuals with pancreatic cancer. The mutations have been sequenced and validated by ATCC. This panel includes p53 wild type cell lines as well as p53 mutant lines that carry hotspot mutations in one of the following codons: 220, 245, 248, 255 and 273.
Product Format
frozen
Storage Conditions
liquid nitrogen vapor phase
友情鏈接
中國林業微生物菌種保藏管理中心
中國工業微生物菌種保藏管理中心
中國普通微生物菌種保藏管理中心
美國國家生物技術信息中心(NCBI)
SIB Bioinformatics Resource Portal
https://www.weibo.com/p/10050
中國典型培養物保藏中心
ATCC菌株、細胞
菌株，慢病毒，細菌，真菌，質粒載體
聯系我們
業務咨詢:0574-87157013
郵箱:mingzhoubio@163.com 浙江省寧波市高新區晶輝路866弄33號智造港E4幢3樓
Copyright ?2019 寧波明舟生物科技有限公司 mingzhoubio.com All Rights Reserved. 浙ICP備19018319號-1
|
